Magnesium L-Threonate & College Athletes
Current research status for the original UCLA MgT trial, with registered outcomes and the historical AMSSM 2026 presentation.
Current research status
Registry source check: October 12, 2026. NCT07015047 lists the trial as active, not recruiting. The record was last updated October 15, 2025 and still gives estimated completion dates. No results are posted in the registry.
Actual study completion: final completion and follow-up dates have not yet been reconciled for this update. The registry check date is not a study-team attestation that data collection or follow-up is complete.
Masking: the 2025 biomedical protocol describes participant and investigator blinding, while the registry lists participant-only masking. The exact approved protocol version, implemented masking roles, and unblinding timing remain to be reconciled. Neither description alone establishes how masking was maintained during the trial.
Analysis status: source records, analysis populations, outcome timing, and the final analysis specification remain under review. The primary registered outcomes are deep-sleep duration and heart rate variability (HRV). Reaction time is secondary. This page does not yet report verified final trial estimates.
Study Overview
The protocol for this single-site, randomized, placebo-controlled trial describes 1 g of magnesium L-threonate (MgT) compound or rice-flour placebo nightly for four weeks in UCLA varsity athletes, with WHOOP monitoring and pre/post performance testing. The registered primary outcomes are deep sleep duration and heart rate variability (HRV), from baseline to Week 4. Reaction-time performance is a registered secondary outcome. Source records and the final analysis specification are being reconciled.
Registered outcomes: final estimates pending
Current status checked October 12, 2026. Both primary outcomes remain visible while the source records and analysis are reconciled.
Interpretation
Reaction time, jump height, grip strength, and subjective sleep quality are registered secondary outcomes. Final estimates, population counts, and multiplicity-adjusted interpretations require verification. Earlier numerical analyses do not establish a treatment benefit or a final null conclusion.
Historical provisional analyses, not final trial results
These earlier web figures are preserved for context. Their analysis dates and source derivations remain unverified. The earlier reported samples were 75 for deep sleep and 107 for paired reaction time; final analysis populations remain under review.
Earlier analysis, n = 75. Analysis date unverified; source and analysis verification pending.
The AMSSM 2026 poster presents an earlier preliminary analysis. Its findings are historical conference reports, not final verified trial estimates.
Preliminary AMSSM 2026 poster findings
These earlier figures are retained for historical context. Both the poster findings and the other historical provisional analyses require reconciliation before final conclusions can be reported. The poster reports 107 participants overall; endpoint and subgroup denominators are not fully specified.
Download the Preliminary AMSSM 2026 Poster
PDF · 1.6 MB · Presented April 2026, Seattle, WA
Archive note, October 12, 2026: this original preliminary poster is preserved unchanged. It is not a verified final result. Read the current research status.
Attribution correction: the original poster misspells coauthor Brian Donohoe's surname.
Study support: the historical poster acknowledges WHOOP for wearable technology and statistical support. This acknowledgment does not establish all current funding or author relationships.
From the Poster Session
Scenes from the AMSSM 35th Annual Meeting poster session in Seattle, where Dr. Kimberly Burbank presented the HERO Lab’s Magnesium L-Threonate pilot trial.
Inclusion Criteria
- Age 18–35 years
- Current UCLA varsity athlete (any sport)
- Actively training or competing during the study period
- Willing to wear a WHOOP strap continuously for 4 weeks
- Willing to ingest a nightly capsule for 4 weeks
- Able to provide informed consent and comply with study procedures
Exclusion Criteria
- Current use of magnesium supplements or investigational drugs
- Use of prescription or over-the-counter sleep medications
- Diagnosed sleep disorder (e.g., insomnia, sleep apnea)
- Major medical condition limiting training or participation
- Pregnancy or breastfeeding
- Known history of chronic kidney or liver disease
- Allergy or intolerance to magnesium
- Inability to comply with study procedures
Outcome Measures
Primary Outcomes
Secondary Outcomes
Investigators
References
Key peer-reviewed literature supporting the rationale and design of this pilot study.
- The Role of Magnesium in Sleep Health: A Systematic Review of Available Literature Arab A, Rafie N, Amani R, Shirani F. Biological Trace Element Research. 2023;201(1):121–128. PMID: 35184264
- Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial Hausenblas HA, Lynch T, Hooper S, Shrestha A, Rosendale D, Gu J. Sleep Medicine: X. 2024;8:100121. PMID: 39252819
- The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial Lopresti AL, Smith SJ. Frontiers in Nutrition. 2026. PMID: 41601871
- Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial Schuster J, Cycelskij I, Lopresti A, Hahn A. Nature and Science of Sleep. 2025. PMID: 40918053
- Enhancement of Learning and Memory by Elevating Brain Magnesium Slutsky I, Abumaria N, Wu LJ, et al. Neuron. 2010;65(2):165–177. PMID: 20152124
- Sleep and Athletic Performance: The Effects of Sleep Loss on Exercise Performance, and Physiological and Cognitive Responses to Exercise Fullagar HHK, Skorski S, Duffield R, et al. Sports Medicine. 2015;45(2):161–186. PMID: 25315456
- A Validation of Six Wearable Devices for Estimating Sleep, Heart Rate and Heart Rate Variability in Healthy Adults Miller DJ, Sargent C, Roach GD. Sensors. 2022;22(16):6317. PMID: 36016077
View on ClinicalTrials.gov
Access the full study record, protocol details, and enrollment status.
NCT07015047Want to get involved?
UCLA varsity athletes can join an active study, and researchers or partners can collaborate with the HERO Lab.